Hall Master Song was recently in high spirits in light of good fortune.
The reception of international guests and visitors had been very successful.
The cancer medication had secured 5 million orders across 15 top-tier countries worldwide.
At 500,000 RMB per dose, the revenue amounted to approximately 2.5 trillion RMB!
After deducting the 20,000 RMB cost of medicinal materials and production per dose, the profit reached 2.4 trillion.
According to the profit-sharing ratio, the Pangu department could get 60%, while Hall Master Song's department would obtain 960 billion!
This made the other three departments—sea, air, and land—envious.
And that was only the initial order quantity, not indicative of the full year.
Once these countries returned and began treating the first batch of patients, based on the current global patient base of over thirty million, it was estimated that the 5 million orders would be exhausted in less than half a year, possibly even faster.
